Relevant bibliographies by topics / Multidrug resistant tuberculosis (MDR-TB)

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Multidrug resistant tuberculosis (MDR-TB)'

Author: Grafiati
Published: 4 June 2021
Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Multidrug resistant tuberculosis (MDR-TB).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Multidrug resistant tuberculosis (MDR-TB)"

1

Paul, Rajput, Singh, and Bera. "A Case Series Study to Assess the Clinical and Socio Demographic Aspects of MDR TB Clients Admitted in Selected Hospitals of Indore." International Journal of Research Publication and Reviews 3, no. 12 (2022): 1656–57. https://doi.org/10.5281/zenodo.7472019.

Full text
Abstract:
The World Health Organization (WHO) defines multidrug-resistant tuberculosis (MDR-TB) as resistance to isoniazid and rifampicin, with or without resistance to other anti-tuberculosis drugs. MDR-TB is a subtype of multidrug-resistant tuberculosis (MDR-TB). It is becoming a significant concern for human health on a global basis, and it presents a threat to the efforts being made to control tuberculosis. According to the most recent statistics on the monitoring of anti-TB drug resistance, it is estimated that 4.3% of newly diagnosed cases and 18% of previously treated cases of tuberculosis across
APA, Harvard, Vancouver, ISO, and other styles
2

Nwachukwu, Ndubuisi O., Amara E. Ulasi, Christopher U. Okoronkwo, and Valentine N. Unegbu. "Pre-extensively drug-resistant tuberculosis among pulmonary multidrug-resistant tuberculosis patients in Eastern Nigeria." Lung India 40, no. 6 (2023): 492–95. http://dx.doi.org/10.4103/lungindia.lungindia_337_23.

Full text
Abstract:
Background: Pre-extensively drug-resistant tuberculosis (Pre-XDR-TB), an emerging form of drug-resistant tuberculosis, is challenging efforts at tuberculosis control, leading to treatment failure among multidrug-resistant tuberculosis (MDR-TB) patients and progression to extensively drug-resistant tuberculosis (XDR-TB). We determined the rate of Pre-XDR-TB among multidrug-resistant patients in Southeast, Nigeria. Methods: A prospective laboratory-based study was carried out at the South East Zonal Tuberculosis Reference Laboratory from January 2021 to December 2021. Second-line drug (SLD) resi
APA, Harvard, Vancouver, ISO, and other styles
3

Caminero, Jose, and Charles Daley. "Management of Multidrug-Resistant Tuberculosis." Seminars in Respiratory and Critical Care Medicine 39, no. 03 (2018): 310–24. http://dx.doi.org/10.1055/s-0038-1661383.

Full text
Abstract:
AbstractDrug-resistant strains of Mycobacterium tuberculosis pose a major threat to global tuberculosis control. Despite the availability of curative antituberculosis therapy for nearly half a century, inappropriate and inadequate treatment of tuberculosis, as well as unchecked transmission of M. tuberculosis, has resulted in alarming levels of drug-resistant tuberculosis. The World Health Organization (WHO) estimates that there were 600,000 cases of multidrug-resistant tuberculosis (MDR-TB)/rifampin-resistant (RR) tuberculosis in 2016, defined as strains that are resistant to at least isoniaz
APA, Harvard, Vancouver, ISO, and other styles
4

Mashidayanti, Aulia, Nurlely Nurlely, and Nani Kartinah. "Faktor Risiko Yang Berpengaruh Pada Kejadian Tuberkulosis dengan Multidrug-Resistant Tuberculosis (MDR-TB) di RSUD Ulin Banjarmasin." Jurnal Pharmascience 7, no. 2 (2020): 139. http://dx.doi.org/10.20527/jps.v7i2.7928.

Full text
Abstract:
MDR-TB (Multidrug-Resistant Tuberculosis) adalah salah satu jenis TB yang resisten dengan OAT (Obat Anti Tuberculosis) dengan resisten terhadap 2 obat anti tuberculosis yang paling ampuh yaitu rifampisin dan isoniazid. Obat rifampisin dan isoniazid sudah tidak efektif dalam membunuh kuman mycobacterium tuberkulosis dikarenakan kuman yang sudah resisten terhadap obat tersebut. MDR-TB merupakan suatu permasalahan yang menjadi hambatan utama dunia dalam pemberantasan TB. Tujuan dari penelitian ini adalah untuk mengidentifikasi faktor risiko apa saja yang dapat berpengaruh pada kejadian tuberkulos
APA, Harvard, Vancouver, ISO, and other styles
5

Paudel, Sita. "Risk Factors of Multidrug-Resistant Tuberculosis." International Journal of Applied Sciences and Biotechnology 5, no. 4 (2017): 548–54. http://dx.doi.org/10.3126/ijasbt.v5i4.18771.

Full text
Abstract:
Multidrug-resistant tuberculosis has been increased worldwide which is a severe problem. A case-control study was carried out among 50 MDR-TB cases and 63 drug susceptible controls to identify risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Lumbini Zone. Irregularity in taking medicine (OR=2.36), large family size (OR=2.40), farming as occupation (OR=2.83), history of TB and bovine at home (OR=6.5) were statistically associated with MDR-TB. Most of the MDR-TB cases were males (82%) and individual with the age group 21-30 years (40%) were highly infected with MDR-TBInt
APA, Harvard, Vancouver, ISO, and other styles
6

Yulianti, Yulianti, and Sally Mahdiani. "Gangguan pendengaran penderita Tuberkulosis Multidrug Resistant." Oto Rhino Laryngologica Indonesiana 45, no. 2 (2015): 83. http://dx.doi.org/10.32637/orli.v45i2.112.

Full text
Abstract:
Latar belakang: Tuberkulosis Multidrug Resistant (TB MDR) merupakan penyakit tuberkulosis (TB) yang resisten terhadap isoniazid dan rifampisin, dengan atau tanpa resisten terhadap obat anti- TB lain. Terapi aminoglikosida pada TB MDR berisiko untuk terjadinya gangguan fungsi telinga dan sistem keseimbangan tubuh, yang dapat bersifat irreversible atau permanen. Kerusakan pada koklea dapat menimbulkan penurunan pendengaran permanen. Tujuan: Mengetahui gangguan pendengaran penderita TB MDR di poliklinik TB MDR Ilmu Penyakit Dalam RS Hasan Sadikin Bandung. Metode: Penelitian deskriptif secara retr
APA, Harvard, Vancouver, ISO, and other styles
7

Huang, Huai, Yu-Shuai Han, Jing Chen, et al. "The novel potential biomarkers for multidrug-resistance tuberculosis using UPLC-Q-TOF-MS." Experimental Biology and Medicine 245, no. 6 (2020): 501–11. http://dx.doi.org/10.1177/1535370220903464.

Full text
Abstract:
The lack of rapid and efficient diagnostics impedes largely the epidemic control of multidrug-resistant tuberculosis, and might misguide the therapeutic strategies as well. This study aimed to identify novel multidrug-resistant tuberculosis biomarkers to improve the early intervention, symptomatic treatment and control of the prevalence of multidrug-resistant tuberculosis. The serum small molecule metabolites in healthy controls, patients with drug-susceptible tuberculosis, and patients with multidrug-resistant tuberculosis were screened using ultra-high-performance liquid chromatography combi
APA, Harvard, Vancouver, ISO, and other styles
8

Rozi, Fahrur, Fakhrun Nisa’ Fiddaroini, and Prawito Prawito. "AGE, GENDER, EDUCATIONAL LEVEL, OCCUPATIONAL, AND KNOWLEDGE LEVEL ABOUT MULTIDRUG RESISTANT TUBERCULOSIS (MDR-TB) AMONG TUBERCULOSIS PATIENTS." Nurse and Holistic Care 3, no. 1 (2023): 39–46. http://dx.doi.org/10.33086/nhc.v3i1.4603.

Full text
Abstract:
Background: Resistance of Mycobacterium Tuberculosis is a condition in which Anti-Tuberculosis (OAT) drugs are unable to kill the Mycobacterium Tuberculosis germs. One type of resistance is Multidrug Resistant Tuberculosis. Multidrug Resistant Tuberculosis (MDR-TB) is TB caused by TB bacteria that are resistant to 2 types of OAT, namely INH and Rifampin. The consequences if resistance to OAT are deterioration of health, increased costs, prolonged treatment, high rates of therapy failure and death.
 Objective: This study aimed to determine relationship between age, gender, educational leve
APA, Harvard, Vancouver, ISO, and other styles
9

Li, Yingying, Yifan Li, Tingting Wang, et al. "Multidrug-resistant Mycobacterium tuberculosis transmission in Shandong, China." Medicine 103, no. 12 (2024): e37617. http://dx.doi.org/10.1097/md.0000000000037617.

Full text
Abstract:
Multidrug-resistant tuberculosis (MDR-TB) has imposed a significant economic and health burden worldwide, notably in China. Using whole genome sequence, we sought to understand the mutation and transmission of MDR-TB in Shandong. A retrospective study of patients diagnosed with pulmonary tuberculosis in Shandong from 2009 to 2018 was conducted. To explore transmission patterns, we performed whole genome sequencing on MDR-TB isolates, identified genomic clusters, and assessed the drug resistance of TB isolates. Our study analyzed 167 isolates of MDR-TB, finding that 100 were clustered. The pred
APA, Harvard, Vancouver, ISO, and other styles
10

Soesanti, Soesanti, and Abd Hakim Husen. "ANALISIS FAKTOR DETERMINAN DEMOGRAFI DENGAN KEJADIAN TUBERCULOSIS MULTIDRUG RESISTANT TUBERCULOSIS (MDR-TB)." NURSING UPDATE : Jurnal Ilmiah Ilmu Keperawatan P-ISSN : 2085-5931 e-ISSN : 2623-2871 13, no. 2 (2022): 43–47. http://dx.doi.org/10.36089/nu.v13i2.730.

Full text
Abstract:
Tuberculosis (TB) is one of the top 10 causes of death worldwide. Multidrug Resistant Tuberculosis (MDR-TB) is TB that is drug resistant to at least 2 (two) most potent anti-TB drugs. This study aims to determine the relationship between age and sex factors with the incidence of Multidrug Resistant Tuberculosis (MDR-TB). This cross-sectional study involved 37 people with pulmonary tuberculosis in the 2019-2021 period which was carried out in the work area of ​​the Ternate City Health Office. Data analysis using chi square test. The results showed that the characteristics of MDR-TB patients in
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Multidrug resistant tuberculosis (MDR-TB)"

1

Adebanjo, Omotayo David. "Knowledge, attittudes and practices of healthcare workers about prevention and control of multidrug-resistant tuberculosis at Botsabelo Hospital Maseru, Lesotho." Thesis, University of Limpopo ( Medunsa Campus), 2011. http://hdl.handle.net/10386/423.

Full text
Abstract:
Thesis (MPH)--University of Limpopo, 2011.<br>Background: Tuberculosis is one of the major public health problems in Lesotho. With the occurrence of multi-drug resistant tuberculosis, little is known about the views of health care workers on this disease. The aim of this study was to investigate the knowledge, attitudes, and practices of healthcare professionals about prevention and control of MDR-TB at Botsabelo hospital, situated in Maseru, Lesotho. Methods: This study was conducted by means of a semi-structured, anonymous, and self-administered questionnaire that was sent to health care wo
APA, Harvard, Vancouver, ISO, and other styles
2

Akçakir, Yasemin. "Correlates of treatment outcomes of multidrug-resistant tuberculosis (MDR-TB): a systematic review and meta-analysis." Thesis, McGill University, 2010. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=86914.

Full text
Abstract:
Background: Multi-drug resistant tuberculosis (MDR-TB) is a major threat to global tuberculosis control. While observational studies have reported outcomes of MDR-TB treatment, there have been no randomized controlled trials for MDR-TB treatment outcomes. We did a systematic review and meta-analysis to examine individual and study-level factors associated with treatment outcomes for MDR-TB in the observational studies.<br>Method: We searched MEDLINE, EMBASE, BIOSIS, Web of Science from 1970 to July 2008, for publications in any language that described at least one treatment outcome among at le
APA, Harvard, Vancouver, ISO, and other styles
3

Smith, Louise. "Resilience of the partners of long term hospitalised patients with multidrug-resistant (MDR) and extreme drug-resistant (XDR) tuberculosis (TB)." Thesis, Nelson Mandela Metropolitan University, 2013. http://hdl.handle.net/10948/d1020913.

Full text
Abstract:
Patients diagnosed with Multidrug-resistant(MDR) and Extreme drug-resistant (XDR) tuberculosis (TB) have to be hospitalised for a period of six to twelve months, according to the MDR/XDR Policy Guidelines on the treatment of drug-resistant TB – until the patient recovers, and is no longer infectious. There are factors associated with both the patients’ and their partners’ (spouses) resistance to long-term hospitalisation. This has resulted in several acts of violence against the hospital property and members of the health-care team. However, there are a small number of partners who assist the
APA, Harvard, Vancouver, ISO, and other styles
4

Souza, Márcia Alves de. "Avaliação do desempenho da PCR Multiplex alelo específico para detecção de genes de Mycobacterium tuberculosis associados à resistência a Rifampicina e Isoniazida, a partir de amostra clínica." Universidade Federal do Amazonas, 2013. http://tede.ufam.edu.br/handle/tede/2565.

Full text
Abstract:
Made available in DSpace on 2015-04-11T13:54:24Z (GMT). No. of bitstreams: 1 Marcia Alves de Souza.pdf: 1923965 bytes, checksum: 3ad1484efad384495579203b0e85259c (MD5) Previous issue date: 2013-05-30<br>FAPEAM - Fundação de Amparo à Pesquisa do Estado do Amazonas<br>A Tuberculose (TB) é uma doença infecciosa causada pelo complexo Mycobacterium tuberculosis, sendo considerada um grave problema de saúde pública mundial. Atualmente, isolados de M. tuberculosis resistentes a pelo menos um medicamento utilizado no tratamento da TB tem sido documentados em todos os países. De acordo com a Organi
APA, Harvard, Vancouver, ISO, and other styles
5

Tinzi, Siphokuhle. "Exploration of experiences of patients with the adverse-drug effects of multidrug-resistant tuberculosis treatment in a primary health care facility in the Western Cape." University of the Western Cape, 2017. http://hdl.handle.net/11394/5660.

Full text
Abstract:
Magister Curationis - MCur<br>Multidrug resistant TB (MDR-TB) is a form of TB caused by bacteria (germs) that are resistant to the usual drugs that are used to treat "normal" TB. The duration of treatment for MDR-TB is a maximum of 22 months. People with MDR-TB are treated in specialized tertiary hospitals and in out-patient clinics in the PHC facilities. The treatment includes a six months injectable phase with a wide range of TB drugs. The adverse effects of MDR-TB drugs are among the worst side effects ever reported by patients. The aim of the current study was to explore the experiences of
APA, Harvard, Vancouver, ISO, and other styles
6

Vallie, Razia. "Assessing and comparing the effectiveness of treatment for multidrug resistant tuberculosis between specialized TB hospital in-patient and general outpatient clinic settings within the Western Cape Province, South Africa." University of the Western Cape, 2016. http://hdl.handle.net/11394/5600.

Full text
Abstract:
Magister Public Health - MPH<br>Background: Multidrug resistant tuberculosis (MDR TB) is a growing threat globally. The large increase in the incidence and prevalence of MDR TB in South Africa in recent years has impacted on the way in which MDR TB is managed within the health services. It became logistically difficult to manage MDR TB by treating all patients as in-patients in a specialized tuberculosis (TB) hospital. The clinics, which are run by nurses and/or general medical officers, are then required to manage this more complex form of TB, with limited resources, less experience an
APA, Harvard, Vancouver, ISO, and other styles
7

Azores, Molovon Jr Pasagui. "Possible Risk Factors for Multidrug-Resistant Tuberculosis Infection in the Philippines." ScholarWorks, 2017. https://scholarworks.waldenu.edu/dissertations/3551.

Full text
Abstract:
Multidrug-resistant Mycobacterium tuberculosis (MDR-TB) is a leading cause of morbidity and mortality in the Philippines. The purpose of this study was to gain knowledge about the relationship between potential risk factors and MDR-TB. Risk factors (the independent variables) for MDR-TB (the dependent variable) include previous TB treatment, infection with HIV, exposure to patients with drug-susceptible TB/MDR-TB, delays in diagnosis and treatment, employment status, smoking, imprisonment, alcohol abuse, and poor compliance with TB treatment regimens. The study was based on the epidemiological
APA, Harvard, Vancouver, ISO, and other styles
8

Visser, Hanri. "Mechanisms of resistance to new generation anti-TB drugs." Thesis, Stellenbosch : Stellenbosch University, 2015. http://hdl.handle.net/10019.1/96863.

Full text
Abstract:
Thesis (MScMedSc)--Stellenbosch University, 2015.<br>ENGLISH ABSTRACT: Drug resistance in Mycobacterium tuberculosis is an increasing global problem. Drug resistance is mostly caused by single nucleotide polymorphisms (SNPs) within the bacterial genome. This observed increase in global incidence of drug resistant tuberculosis (TB) has sparked the search for new anti-TB drugs and the repurposing of drugs that are currently used against other organisms or species of mycobacteria. One such repurposed drug, clofazimine (CFZ), is currently used for the treatment of leprosy, caused by Mycobacterium
APA, Harvard, Vancouver, ISO, and other styles
9

Franco, Marília Masello Junqueira. "Genotipagem e pesquisa de resistência fenotípica e genética à rifampicina e isoniazida em linhagens de Mycobacterium bovis isoladas de linfonodos de bovinos de abatedouro na região centro-oeste do estado de São Paulo." Botucatu, 2016. http://hdl.handle.net/11449/143102.

Full text
Abstract:
Orientador: Antonio Carlos Paes<br>Resumo: A tuberculose causada por Mycobacterium bovis (bTB) é uma zoonose de distribuição mundial com ampla gama de hospedeiros. Nos países onde a bTB é prevalente, 10 a 20% dos casos de tuberculose humana são causados por M. bovis. São escassos em todo o mundo estudos que investigam a resistência à isoniazida (INH) e rifampicina (RMP) em linhagens de M. bovis de origem bovina, reservatórios silvestres, e em casos humanos de tuberculose. Foi investigada a diversidade genotípica de 67 linhagens de M. bovis isoladas de bovinos de abatedouro, obtidas de 100 linf
APA, Harvard, Vancouver, ISO, and other styles
10

Pule, Caroline. "Defining the role of efflux pump inhibitors on anti-TB drugs in Rifampicin resistant clinical Mycobacterium Tuberculosis isolates." Thesis, Stellenbosch : Stellenbosch University, 2014. http://hdl.handle.net/10019.1/86758.

Full text
Abstract:
Thesis (MScMedSc)--Stellenbosch University, 2014.<br>ENGLISH ABSTRACT: Central dogma suggests that mutations in target genes is the primary cause of resistance to first and second-line anti-TB drugs in Mycobacterium tuberculosis. However, it was previously reported that approximately 5% of Rifampicin mono-resistant clinical M. tuberculosis did not harbor mutations in the rpoB gene. The present study hypothesized that active efflux plays a contributory role in the level of intrinsic resistance to different anti-TB drugs (Isoniazid, Ethionamide, Pyrazinamide, Ethambutol, Ofloxacin, Moxifloxacin,
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Multidrug resistant tuberculosis (MDR-TB)"

1

(Geneva), WHO, and Gupta Rajesh, eds. Guidelines for establishing DOTS-Plus pilot projects for the management of multidrug-resistant tuberculosis (MDR-TB). World health organization (WHO), 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rocío, Valverde Aliaga, and Partners in Health (Organization). Sucursal Perú., eds. Venciendo la TB-MDR: 20 testimonios de expacientes con tuberculosis multidrogo resistente. Socios en Salud Sucursal Perú, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Vinšová, Jarmila. Development of new MDR-tuberculosis drugs. Nova Science Publisher, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

World Health Organization (WHO). Management of MDR-TB: A field guide, a companion document to Guidelines for the programmatic management of drug-resistant tuberculosis. World Health Organization, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wiegandt, Axel. Framework to address multi-drug-resistant TB in the Pacific island countries and territories. Secretariat of the Pacific community, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Border, Peter. Diseases fighting back: The growing resistance of TB and other bacterial diseases to treatment. Parliamentary Office of Science and Technology, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chronic care for MDR-TB: Guidelines for health centre or district hospital TB clinic. Partners in Health, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wilker, Ian, and Evelyn B. Kelly. Tuberculosis and Superbugs: Examining TB and Bacterial Infections. Enslow Publishing, LLC, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hadiarto, Mangunnegoro. Present Situation of Multidrug-Resistant Tuberculosis & the Possibility of Mdr-Tb Treatment by New Quinolones: Proceedings of a Satellite Symposium for ... of the Chest, Bali, June 1996 (Chemotherapy). S Karger Pub, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Multidrug resistant tuberculosis (MDR-TB)"

1

Bensard, Denis D., Philip F. Stahel, Jorge Cerdá, et al. "Multidrug-Resistant Tuberculosis (MDR TB)." In Encyclopedia of Intensive Care Medicine. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-00418-6_3209.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

McAuslane, Helen, and Dominik Zenner. "Multidrug-Resistant Tuberculosis (MDR-TB)." In Case Studies in Infection Control. Garland Science, 2018. http://dx.doi.org/10.1201/9780203733318-12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Silesky-Jiménez, Juan Ignacio. "Tuberculosis Multidrug Resistance (MDR-TB)." In Highly Infectious Diseases in Critical Care. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-33803-9_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Nguyen, Binh, Greg J. Fox, Paul H. Mason, and Justin T. Denholm. "Preventive Therapy for Multidrug Resistant Latent Tuberculosis Infection: An Ethical Imperative with Ethical Barriers to Implementation?" In Ethics and Drug Resistance: Collective Responsibility for Global Public Health. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-27874-8_2.

Full text
Abstract:
Abstract Multidrug resistant tuberculosis (MDR-TB) has a substantial impact on individuals and communities globally, including lengthy, expensive and burdensome therapy with high rates of treatment failure and death. Strategies to prevent disease are well established for those who acquire latent tuberculosis infection (LTBI) after exposure to drug susceptible TB (DS-TB). However, there has been limited research or programmatic experience regarding the prevention of MDR-TB. Accordingly, while global recommendations strongly emphasize the need to deliver LTBI therapy after TB exposure, most prog
APA, Harvard, Vancouver, ISO, and other styles
5

Inayati, Qori’atul Putri Nurmala, and Hasto Nugroho. "Tuberculosis Treatment History Influenced Multidrug-Resistant Tuberculosis (MDR-TB) Incidence Based on Gene-Xpert Examination." In Proceedings of the International Conference on Sustainable Innovation on Health Sciences and Nursing (ICOSI-HSN 2022). Atlantis Press International BV, 2022. http://dx.doi.org/10.2991/978-94-6463-070-1_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sutandi, Aan, Martika Hijriani, Apriana Rahmawati, and Harizza Pertiwi. "The Role of Knowledge and Motivation in Multidrug-Resistant Tuberculosis (MDR-TB) Incidence." In Advances in Health Sciences Research. Atlantis Press International BV, 2025. https://doi.org/10.2991/978-94-6463-774-8_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Shawa, Remmy, Fons Coomans, Helen Cox, and Leslie London. "Access to Effective Diagnosis and Treatment for Drug-Resistant Tuberculosis: Deepening the Human Rights-Based Approach." In Ethics and Drug Resistance: Collective Responsibility for Global Public Health. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-27874-8_10.

Full text
Abstract:
Abstract The lack of access to effective diagnosis and treatment for drug-resistant tuberculosis (DR-TB) remains a persistent ethical, human rights and public health challenge globally. In addressing this challenge, arguments based on a Human Rights-Based Approach (HRBA) to health have most often been focused on the Right to Health. However, a key challenge in multidrug-resistant (MDR-) and extensively drug-resistant (XDR-) TB is the glaring absence of scientific research; ranging from basic science and drug discovery through to implementation science once new tools have been developed. Althou
APA, Harvard, Vancouver, ISO, and other styles
8

Upadhyay, Tarun K., Akanksha Sharma, Nida Fatima, Amit Singh, Pavan Muttil, and Rolee Sharma. "Targeted Delivery of Antibiotics Using Microparticles to Combat Multidrug-Resistant Tuberculosis." In Antibacterial Drug Discovery to Combat MDR. Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-9871-1_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Setiawan, Andy, Pramudya Pramudya, and Hasyrin Ainun. "Analysis Of the Concept of Self-Care In Multidrug Resistance Tuberculosis (MDR-TB) Patients." In Advances in Health Sciences Research. Atlantis Press International BV, 2024. http://dx.doi.org/10.2991/978-94-6463-467-9_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Setiawan, Andy, Pramudya, and Hasyrin Ainun. "Analysis of the Concept of Self-Care in Multidrug Resistance Tuberculosis (MDR-TB) Patients." In Advances in Biological Sciences Research. Atlantis Press International BV, 2024. http://dx.doi.org/10.2991/978-94-6463-457-0_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Multidrug resistant tuberculosis (MDR-TB)"

1

Kurnianingsih, Widya, Didik Gunawan Tamtomo, and Bhisma Murti. "Incomplete Medication Intake and Multidrug Resistant Tuberculosis." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.01.58.

Full text
Abstract:
Background: Multidrug Resistant Tuberculosis (MDR-TB) is a highest problem in the prevention and eradication of TB worldwide. MDR-TB exists in 27 countries where there are at least 6,800 MDR-TB cases annually and 12% of new TB cases registered are MDR TB. This study aimed to examine the effect of incomplete medication intake on the incidence of MDR TB. Subjects and Method: Meta-analysis and systematic review was conducted by collecting articles from Google Scholar, Pubmed, and Springer Link databases, from year 2010 to 2019. Keywords used “Risk Factor MDR TB” OR “Previous Treatment” AND “Multi
APA, Harvard, Vancouver, ISO, and other styles
2

Falzon, Dennis, Ernesto Jaramillo, and Karin Weyer. "Multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB) : global response." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.oa1944.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Babalık, Aylin, Ayse Rumeysa Hazine, Gul Erdal Donmez, et al. "Evaluation of 123 Cases with MDR TB (Multidrug Resistant Tuberculosis) Treatment." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa4745.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Guglielmetti, L., U. Khan, GE Velasquez, et al. "Improving treatment of multidrug-resistant tuberculosis: Results of the endTB randomised clinical trial." In MSF Scientific Days International 2024. MSF-USA, 2024. http://dx.doi.org/10.57740/ijraistot9.

Full text
Abstract:
INTRODUCTION Tuberculosis (TB) is a major public health challenge encountered across many Médecins Sans Frontières (MSF) fields. Management of drug-resistant TB is an operational priority for MSF. endTB is an MSF-sponsored randomised trial funded by Unitaid as part of the larger endTB project. The trial objective was to examine five new all-oral, shortened regimens for patients with fluoroquinolone-susceptible, rifampicin-resistant/multidrug- resistant TB (RR/MDR-TB). METHODS endTB was a phase 3, randomised, controlled, non-inferiority trial performed in seven countries (Georgia, India, Kazakh
APA, Harvard, Vancouver, ISO, and other styles
5

Karaman, Onur, Yelda Varol, Can Bicmen, Tülay Akarca, Sevket Dereli, and Didem Ozbakır. "Treatment Results of Multidrug Resistant Tuberculosis (MDR-TB) Patients in the Aegean Region." In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.pa3348.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ratomaharo, J., R. Andriamihaja, V. Andriananja, R. Rakotoarivelo, R. M. Andrianasolo, and M. Randria. "Characterazing Multidrug- Resistant Tuberculosis (MDR-TB) in Madagascar: A Real Threat to Health Security." In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a2342.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

de Luca e Tuma, Ricardo, Amina Jama, Susan Dart, et al. "Multidrug resistant tuberculosis (MDR-TB) incidence in close contacts of pulmonary MDR-TB index cases in East London - a retrospective study." In ERS Congress 2024 abstracts. European Respiratory Society, 2024. http://dx.doi.org/10.1183/13993003.congress-2024.pa2362.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Shinta, Mega, Sabaniah Indjar Gama, and Adam M. Ramadhan. "KAJIAN PENGOBATAN DAN KEPATUHAN PASIEN MULTIDRUG-RESISTANT TUBERCULOSIS (MDR-TB) DI RSUD A.W SJAHRANIE SAMARINDA." In the 4th Mulawarman Pharmaceuticals Conferences. Fakultas Farmasi, Universitas Mulawarman, Samarinda, 2016. http://dx.doi.org/10.25026/mpc.v4i1.182.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Zaman, F., and M. Asaduzzaman. "Priority identification in the clinical case management of multidrug resistant Tuberculosis (MDR-TB) in Bangladesh." In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.1122.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Mansoor, H., N. Hirani, VV Chavan, et al. "Clinical utility of target-based next-generation sequencing for drug-resistant tuberculosis: a pilot from Mumbai, India." In MSF Scientific Days International 2022. MSF-USA, 2022. http://dx.doi.org/10.57740/atfq-6s03.

Full text
Abstract:
INTRODUCTION In countries with a high tuberculosis (TB) burden, poor access to drug susceptibility testing is a major bottleneck in diagnosing drug-resistant (DR) TB. India is estimated to account for a quarter of multidrug-resistant (MDR)-TB patients globally, with around 124,000 cases in 2020. Mumbai, a densely populated city in Maharashtra State, is a DR-TB hotspot with 24% of treatment- naïve cases, and 41% of previously-treated cases, having MDR-TB, and a high frequency of fluoroquinolone resistance occurring among these MDR-TB cases. Targeted next- generation sequencing (tNGS) is a promi
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Multidrug resistant tuberculosis (MDR-TB)' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography